Strategic Intentions 2024–2028

Source: New Zealand Ministry of Health

Summary

The Strategic Intentions 2024–2028 is how the Ministry informs Parliament and the public about:

  1. the strategic objectives that the Ministry intends to achieve or contribute to over the medium term
  2. what the Ministry intends to achieve with appropriations
  3. the nature and scope of the Ministry’s functions and operations to achieve or contribute to the strategic objectives.

There are three main sections.

  • Section one – introduction, including our purpose, functions and responsibilities, and our context
  • Section two – our strategic direction, which includes our strategic priorities and priority activities
  • Section three – how we operate as an organisation to achieve our strategic intentions. 

The document sets out the Ministry’s own strategic focus, functions and priorities aligned and contributing to, but distinct from those of the Government. 

The Ministry is responsible for reporting annually on progress against the Strategic Intentions 2024–2028 and what has been achieved with appropriations. Parliament sees information on performance reporting in the Ministry’s annual reports and information supporting the Estimates.

The Ministry’s Strategic Intentions 2024–2028 also includes the strategic intentions of Te Aho o Te Kahu – Cancer Control Agency. The agency is a departmental agency hosted by the Ministry and is operating within the Ministry’s strategic and policy framework.

Health National Adaptation Plan 2024 – 2027

Source: New Zealand Ministry of Health

Our climate is changing. These changes are affecting what we value most in our lives, including our health and wellbeing.

This first Health National Adaptation Plan (HNAP) is an important step towards placing health considerations at the forefront of the climate response of Aotearoa New Zealand. It sets the strategic direction and provides national-level priority actions for health-focused adaptation to climate change. 

The vision for the HNAP is ‘to protect the health and wellbeing of people and communities from the effects of climate change to achieve pae ora – healthy futures for all New Zealanders’. The aim of this deliberately broad scope is to ensure the health system can provide climate-resilient health services, while also addressing the broader direct and indirect effects of climate change on the health of communities, including those effects that sectors outside the health system contribute to.

The Ministry of Health – Manatū Hauora has developed the HNAP as an action arising from New Zealand’s first National Adaptation Plan. The HNAP also reflects the health system’s own mandate to respond to climate change, most recently reiterated in the Government Policy Statement (GPS) on Health 2024 – 2027.   

Health warning of extreme risk for Lake Rotoroa (Hamilton Lake) lifted, though a health warning remains in place

Source: Waikato District Health Board

The Public Health warning of extreme risk for Lake Rotorua issued on 19th July 2024 has now been lifted. This is due to significant reductions in the concentration of cyanobacterial biovolumes, which earlier prompted the increased level of risk and vigilance. Please note a health warning still remains in place at Lake Rotoroa (Hamilton Lake), as cyanobacterial levels continue to be above the warning levels.

Lakes Hakanoa, Waikare, Rotokauri, Whangape and Kainui also continue to have a cyanobacterial health warning in place.

Dr Richard Vipond, Health New Zealand – Te Whatu Ora Medical Officer of Health for Waikato recommends that where cyanobacteria health warnings are in place, lakes should not be used for any activity that involves skin contact with the affected water.

“Swallowing water from lakes affected by blooms should also be avoided,” said Dr Vipond.

“Cyanobacteria can release toxins which can trigger asthma and hayfever symptoms, and can cause skin rashes, stomach upsets, and in some cases neurological effects such as tingling around the mouth, headaches, breathing difficulties and visual problems.

“These symptoms may not appear until some time after contact with the affected water.

“Scums are a particular risk because they contain a high level of toxins.  If contact with scum does occur, skin should be rinsed clean and clothing changed as soon as possible. This warning is particularly important for children.

“If people do come into contact with the lake when warnings are in place, or any other lake where there are visible changes to water colour, they should shower and change their clothing as soon as possible afterwards, even if no symptoms are noticeable,” he said.

Dog owners should prevent their dogs from drinking or swimming in the water, as dogs are particularly sensitive to cyanobacteria.

Up-to-date information on cyanobacterial cell counts is available by visiting the Land Air Water Aotearoa (LAWA) website at https://www.lawa.org.nz/explore-data/waikato-region/

National Public Health Service – Waikato would like to be informed about health problems that develop after exposure to any of the lakes with health warnings in place. Please contact on (07) 838 2569.

Drug checking licensing scheme testing methods amendment form

Source: New Zealand Ministry of Health

If a licensed provider wishes to use a drug checking testing method not on the approved lists (Table 2 and Table 3 on the Ministry of Health drug checking webpage), or to use a method they are not currently licensed for, they will need to satisfy the Director-General of Health (or delegated authority) that the technology is safe to implement and fit for its intended purpose. Licensed providers must show that their workforce is competent to use the drug checking testing methodology before they will receive approval. New testing methods can only be used by a licensed provider once written approval is received from the drug checking licensing team and the provider is licensed to do so.

Complete the following information for any requested additions of drug checking testing methods to a provider’s licence.

Drug checking licensing scheme service delivery model amendment form

Source: New Zealand Ministry of Health

If a licensed provider wishes to use a service delivery model not on the approved list (Table 1 of the Ministry of Health drug checking webpage), or wishes to use a model not currently licensed for, they will need to satisfy the Director-General of Health (or delegated authority) that the model is safe to implement and fit for its intended purpose. Licensed providers must show that their workforce is competent to use a service delivery model before they will receive approval. New models can only be used by a licensed provider once written approval is received from the drug checking licensing team and the provider is licensed to do so.

Complete this form for any requested addition of drug checking service models to a provider’s licence.

Fluffy, super snuggly and loves people!

Source: Waikato District Health Board

L-R Waikato ED staff enjoying a visit from Amethyst – Kneeling – Tanya Suthers, Amethyst, Back – Rushi Jeyakumar, Lillian Pan, Lynne Kemp, Rhi Buckley and Collene Pacis

According to registered nurse Lynne Kemp, these are just some of the qualities needed for being a successful therapy dog. Lynne is talking about Amethyst, her 17-month-old Border Collie, who visits Waikato Hospital’s emergency department (ED) once a week.

Amethyst and Lynne are registered with Canine Friends Pet Therapy, a New Zealand-wide network of owners who bring their dogs to visit people in hospitals and residential care facilities.

“I started working with Canine Friends about four years ago, with Sapphire, my six-year-old long-haired Weimaraner,” says Lynne. “I love doing things with my dogs, and I loved the idea of being able to bring my dog to work. When I heard the ED was considering a canine therapy programme, I jumped at the chance to be involved.”

At Waikato Hospital, therapy dogs already visit the Critical Care Unit, Paediatric wards and others, but Emergency Medicine Consultant Dr Lillian Pan could see the positive impact they would have in the ED.

“The benefits of pet therapy are well established,” says Lillian. “But there are only a handful of studies done in emergency departments.

“A 2022 Canadian study demonstrated a significant reduction in pain, anxiety and depression after a 10-minute therapy dog visit, and an American study from 2019 noted that patients who interacted with therapy dogs needed less opioid pain medication during their ED stay.

“We wanted to gauge how people would feel if we brought dogs into our ED. We surveyed a total of 126 staff, patients and whānau and the response was overwhelmingly positive, with 93% in favour.

“The comments ranged from ‘People would love this, especially the kids’ and ‘When people see dogs in an unusual setting, it makes them focus less on their pain or trauma’, to ‘Just pure unconditional love – what’s not to love?’” says Lillian.

“It’s often a scary experience coming into the ED, with lots of people and plenty of activity going on,” adds Lynne. “Interacting with a dog is a great distraction, and it seems to have a calming effect on patients and whānau.”

That initial proposal was put forward over a year ago and, since July, Lynne and Amethyst have been visiting Waikato ED once a week to spend time with paediatric and short-stay patients. A staff volunteer acts as a ‘doggie chaperone’ and pre-screens patients for suitability, while care is taken for infection control and hygiene.

Just last week, they had a special encounter with a 10-year-old girl.

“I entered the room and Amethyst went over to her. Her whole face lit up with the biggest smile,” says Lynne.  “Her mum said that was the first time she had seen her smile since their arrival the day before.

“It was so heartwarming to see, and reinforced the reason for my visits,” she says.

The visits are not just for patients, either. Both Lynne and Lillian are quick to emphasise how beneficial canine therapy is for the ED’s kaimahi.

“Amethyst’s visits brighten everyone’s day. It’s good for staff, especially when it’s busy and they have upsetting cases to deal with,” says Lynne.

So, what makes a paw-fect therapy dog?

L-R Lyn Kemp and Amethyst spent some time with patient Jan who thought Amethsyt was just lovely

“My dog Frankie, an eight-year-old Bichon Frise, is ideally suited to being a therapy dog and regularly visits a local nursing home. He’s calm, loves everyone and is happiest when he’s the centre of attention – especially if there are treats involved,” says Lillian.

“When I first visited a rest home with Sapphire, it didn’t go so well. There was a cat that Sapphire spent all her time trying to find! So being calm and not easily distracted is important,” explains Lynne.

Lillian agrees: “Dougal, my other dog, is a little scamp and would cause chaos if he ever went on a visit!” she laughs.

There has been tremendous support from staff to get the project off the ground. The Critical Care Team shared information about their therapy dog mahi, and Lillian had two ED trainees, Rushi Jeyakumar and Julie Taylor, to support the ED programme with her. ED leadership staff Liz Courtney and Simon Ainsworth were instrumental in pushing the project ahead.

Lillian says the benefits of pet therapy in emergency departments is a topic that needs further exploration within the medical community. “Implementing this programme gives Waikato Hospital ED a unique opportunity to contribute to further research in the area,” she says.

“I love coming in with Amethyst. Even though we are only there for an hour, seeing the happiness she brings is lovely,” adds Lynne.

Evidence Brief: Invasive group A streptococcus and skin infections

Source: New Zealand Ministry of Health

Summary

Group A streptococcus (GAS) bacteria is a pervasive pathogen, spread through airborne droplets and skin-to-skin contact, that may lead to invasive group A streptococcus (iGAS), post-streptococcal glomerulonephritis (PSGN), acute rheumatic fever (ARF) or rheumatic heart disease (RHD). The onset of iGAS is often sudden, and the disease progresses rapidly. It can result in serious health outcomes such as loss of limbs or severe scarring, brain damage, hearing loss or learning disabilities. Without timely treatment, sepsis can rapidly lead to tissue damage, organ failure and death. 

People with socio-economic disadvantage are at greater risk of GAS and iGAS infections; the prevalence of GAS infections is commonly associated with low-quality and inadequate housing. Lack of access to clean water, homelessness and drug injection are other contributing risk factors. 

Physiologically, the role of GAS infections in pharyngitis is well understood, likely because of its role in the sequalae of ARF. However, there is increasing recognition of the role of GAS skin infections in the development of iGAS, ARF, RHD and PSGN.

Since 2022, the number of iGAS cases reported has increased internationally, including in New Zealand. Case rates have increased beyond those recorded in 2017 (pre-COVID-19 pandemic), and cases in 2023 showed large ethnic disparities. In 2023, the decision was made to start the process to make iGAS a notifiable disease in New Zealand. The Deputy Director of Public Health commissioned this evidence brief in anticipation of iGAS being made a notifiable disease in 2024.

The brief reports on a systematic review of the prevalence of GAS skin infections in cases of iGAS, ARF, RHD and PSGN. It also reports on a scoping review of the evidence on risk factors and prevention of GAS skin infections and provides an analysis of knowledge gaps within the current evidence to inform future research priorities.

Pilot public transport subsidy concludes

Source: Waikato District Health Board

The public transport subsidy pilot launched on 16 October 2023 as a collaborative effort between Health New Zealand |Te Whatu Ora and Waikato Regional Council ends on 30 September.

During the trial, passengers using their Bee Card to get on or off the bus at the Pembroke Street and Hague Road stops would get an automatic 50 percent discount on the fare. Health NZ Waikato Operations Director for Clinical and Operational Support, Melinda Ch’Ng said the number of bus passengers had increased during the trial which was a benefit to the environment and reduced pressure on hospital parking for patients and staff. However, the funding for this pilot finishes on 30 September.

Other public transport enhancements set up during the pilot will continue past the end date, including the provision of additional buses to accommodate more people using the service, and adjusted bus timetables to align with staff shift hours. Designated transport hub parking was also made available, allowing staff to conveniently park near bus routes.

Although we are no longer able to cover the subsidy, Melinda says it doesn’t mean you should stop using public transport and Bee cards will continue to be available from the hospital cafes.

“Buses remain a convenient and cost-effective way to reach Waikato Hospital and by continuing to use them you can avoid the stress of finding parking, while contributing to a more sustainable future.

For more information about Hamilton and regional buses visit busit.co.nz or call 0800 205 305.